SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling

FEBS Journal

Volumn 282, Issue 8, 2015, Pages 1394-1405

  Mansour, Mohammed A ^a,b   Hyodo, Toshinori ^a   Ito, Satoko ^a   Kurita, Kenji ^a   Kokuryo, Toshio ^a   Uehara, Keisuke ^a   Nagino, Masato ^a   Takahashi, Masahide ^a   Hamaguchi, Michinari ^a   Senga, Takeshi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tanta University   (Egypt)

Author keywords

colorectal cancer; ERK5; invasion; migration; SATB2

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MAP2K5 PROTEIN, HUMAN; MATRIX ATTACHMENT REGION BINDING PROTEIN; MESSENGER RNA; SATB2 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MIGRATION INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SATB2 GENE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CANCER STAGING; CELL ADHESION; CELL MOTION; COLORECTAL TUMOR; DISEASE COURSE; DRUG SCREENING; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING; WOUND HEALING;

ADULT; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MAP KINASE KINASE 5; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 7; NEOPLASM STAGING; PHOSPHORYLATION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; WOUND HEALING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84927737496     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13227     Document Type: Article

References (35)

1. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, &, Starling N, (2010) Colorectal cancer. Lancet 375, 1030-1047.
2. FitzPatrick D, Carr I, McLaren L, Leek J, Wightman P, Williamson K, Gautier P, McGill N, Hayward C, Firth H, et al,. (2003) Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum Mol Genet 12, 2491-2501.
3. Britanova O, Akopov S, Lukyanov S, Gruss P, &, Tarabykin V, (2005) Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS. Eur J Neurosci 21, 658-668.
4. Gyorgy A, Szemes M, De Juan Romero C, Tarabykin V, &, Agoston D, (2008) SATB2 interacts with chromatin-remodeling molecules in differentiating cortical neurons. Eur J Neurosci 27, 865-873.
5. Dobreva G, Chahrour M, Dautzenberg M, Chirivella L, Kanzler B, Farinas I, Karsenty G, &, Grosschedl R, (2006) SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125, 971-986.
6. Alcamo E, Chirivella L, Dautzenberg M, Dobreva G, Farinas I, Grosschedl R, &, McConnell S, (2008) Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron 57, 364-377.
7. Britanova O, de Juan Romero C, Cheung A, Kwan K, Schwark M, Gyorgy A, Vogel T, Akopov S, Mitkovski M, Agoston D, et al,. (2008) Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. Neuron 57, 378-392.
8. Hassan M, Gordon J, Beloti M, Croce C, Van Wijnen A, Stein J, Stein G, &, Lian J, (2010) A network connecting Runx2, SATB2, and the miR-23a∼ 27a-24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA 107, 19 879-19884.
9. Beaty T, Hetmanski J, Fallin M, Park J, Sull J, McIntosh I, Liang K, Vanderkolk C, Redett R, Boyadjiev S, et al,. (2006) Analysis of candidate genes on chromosome 2 in oral cleft case-parent trios from three populations. Hum Genet 120, 501-518.
10. Britanova O, Depew M, Schwark M, Thomas B, Miletich I, Sharpe P, &, Tarabykin V, (2006) Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development. Am J Hum Genet 79, 668-678.
11. Leoyklang P, Suphapeetiporn K, Siriwan P, Desudchit T, Chaowanapanja P, Gahl W, &, Shotelersuk V, (2007) Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects. Hum Mutat 28, 732-738.
12. Rosenfeld J, Ballif B, Lucas A, Spence E, Powell C, Aylsworth A, Torchia B, &, Shaffer L, (2009) Small deletions of SATB2 cause some of the clinical features of the 2q33. 1 microdeletion syndrome. PLoS One 4, 6568.
13. Balasubramanian M, Smith K, Basel-Vanagaite L, Feingold M, Brock P, Gowans G, Vasudevan P, Cresswell L, Taylor E, Harris C, et al,. (2011) Case series: 2q33. 1 microdeletion syndrome-further delineation of the phenotype. J Med Genet 48, 290-298.
14. Docker D, Schubach M, Menzel M, Munz M, Spaich C, Biskup S, &, Bartholdi D, (2013) Further delineation of the SATB2 phenotype. Eur J Hum Genet 22, 1034-1039.
15. Dobreva G, Dambacher J, &, Grosschedl R, (2003) SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev 17, 3048-3061.
16. Liu T, Xu L, Yang A, Zhong Q, Song M, Li M, Hu L, Chen F, Hu Z, Han P, et al,. (2012) Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients. PLoS One 7, 40704.
17. Wang S, Zhou J, Wang X, Hao J, Chen J, Zhang X, Jin H, Liu L, Zhang Y, Liu J, et al,. (2009) Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol 219, 114-122.
18. Eberhard J, Gaber A, Wangefjord S, Nodin B, Uhlen M, Lindquist K, &, Jirstrom K, (2012) A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. Br J Cancer 106, 931-938.
19. Yang M, Yu J, Chen N, Wang X, Liu X, Wang S, &, Ding Y, (2013) Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2. PLoS One 8, 85353.
20. Shah N, &, Sukumar S, (2010) The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10, 361-371.
21. Galande S, Dickinson L, Mian I, Sikorska M, &, Kohwi-Shigematsu T, (2001) SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis. Mol Cell Biol 21, 5591-5604.
22. Nithianandarajah-Jones G, Wilm B, Goldring C, Muller J, &, Cross M, (2012) ERK5: structure, regulation and function. Cell Signal 24, 2187-2196.
23. Lochhead P, Gilley R, &, Cook S, (2012) ERK5 and its role in tumour development. Biochem Soc Trans 40, 251-256.
24. Hu B, Ren D, Su D, Lin H, Xian Z, Wan X, Zhang J, Fu X, Jiang L, Diao D, et al,. (2012) Expression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer. BMC Cancer 12, 127.
25. Mehta P, Jenkins B, McCarthy L, Thilak L, Robson C, Neal D, &, Leung H, (2003) MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene 22, 1381-1389.
26. Barros J, &, Marshall C, (2005) Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton. J Cell Sci 118, 1663-1671.
27. Gong Y, Xu F, Zhang L, Qian Y, Chen J, Huang H, &, Yu Y, (2014) MicroRNA expression signature for Satb2-induced osteogenic differentiation in bone marrow stromal cells. Mol Cell Biochem 387, 227-239.
28. Kohwi-Shigematsu T, Poterlowicz K, Ordinario E, Han H, Botchkarev V, &, Kohwi Y, (2013) Genome organizing function of SATB1 in tumor progression. Semin Cancer Biol 23, 72-79.
29. Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu S, Liu K, Wu K, &, Tong Q, (2010) Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS 118, 855-863.
30. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, Wang G, Shu X, Wu K, Liu K, &, Tong Q, (2010) SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 24, 981-987.
31. Chen H, Takahara M, Oba J, Xie L, Chiba T, Takeuchi S, Tu Y, Nakahara T, Uchi H, Moroi Y, et al,. (2011) Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci 64, 39-44.
32. Yanagisawa J, Ando J, Nakayama J, Kohwi Y, &, Kohwi-Shigematsu T, (1996) A matrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues. Cancer Res 56, 457-462.
33. Han H, Russo J, Kohwi Y, &, Kohwi-Shigematsu T, (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452, 187-193.
34. Fromberg A, Rabe M, &, Aigner A, (2014) Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma. Int J Cancer 135, 2537-2546.
35. Savarese F, Davila A, Nechanitzky R, De La Rosa-Velazquez I, Pereira C, Engelke R, Takahashi K, Jenuwein T, Kohwi-Shigematsu T, Fisher A, et al,. (2009) Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression. Genes Dev 23, 2625-2638.